Penobscot Investment Management Company, Inc. Bristol Myers Squibb CO Transaction History
Penobscot Investment Management Company, Inc.
- $1.27 Billion
- Q3 2025
A detailed history of Penobscot Investment Management Company, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Penobscot Investment Management Company, Inc. holds 15,078 shares of BMY stock, worth $694,643. This represents 0.05% of its overall portfolio holdings.
Number of Shares
15,078
Previous 15,618
3.46%
Holding current value
$694,643
Previous $722,000
5.82%
% of portfolio
0.05%
Previous 0.06%
Shares
22 transactions
Others Institutions Holding BMY
# of Institutions
2,664Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.98 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.31 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.98 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.36 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.26 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $98B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...